Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

Summary by GEN - Genetic Engineering and Biotechnology News…
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business unit, established a U.S.-based subsidiary for its CDMO services. The new subsidiary, incorporated in Delaware, will operate under the name Scinai Bioservices. Scinai launched its CDMO business unit earlier this year, which operates from the company’s site in Jerusalem. The faci…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)